ALIMTA (pemetrexed for injection) [package insert]. Indianapolis, IN: Eli Lilly and Company; Langer CJ, et al. Lancet Oncol. ;17(11) Learn how ALIMTA may help treat advanced nonsquamous non-small cell lung cancer. ALIMTA and carboplatin (carbo) is approved by the FDA to be used with an the FDA in combination with carboplatin (another chemotherapy drug) and. Read all of this leaflet carefully before you start receiving this medicine because it contains important information for you. -. Keep this leaflet. You may need to.

Author: Mazuzshura Mitaur
Country: Libya
Language: English (Spanish)
Genre: Art
Published (Last): 6 August 2015
Pages: 170
PDF File Size: 4.74 Mb
ePub File Size: 2.24 Mb
ISBN: 506-3-81387-283-1
Downloads: 33944
Price: Free* [*Free Regsitration Required]
Uploader: Mikazshura

This may affect your ability to father a child. The infusion is given over 10 minutes. ALIMTA is indicated as a single agent for the maintenance treatment of patients with aoimta advanced or metastatic nonsquamous non-small cell lung cancer NSCLC whose disease has not progressed after four cycles of platinum-based first-line chemotherapy.

Withhold ALIMTA for acute onset of new or progressive unexplained pulmonary symptoms such as dyspnea, cough, or fever pending diagnostic evaluation. Accessed June 27, Low blood cell counts can be severe, including low white blood cell counts neutropenialow platelet counts thrombocytopeniaand low red blood cell counts anemia.

Your healthcare provider may change your dose of ALIMTA, delay treatment, or stop treatment if you have certain side effects.

Tell your healthcare provider right away if you have packafe decrease in amount of urine. You are encouraged to report negative side effects of prescription drugs to the FDA. Hold on longer to what matters most. It is not known if these effects are reversible.


ALIMTA® (pemetrexed): Storage of Unreconstituted Vials

Eli Lilly and Company; Tell your healthcare provider if you have any side effect that bothers you or that does not go away. This indication is approved under accelerated approval based on tumor response rate and progression-free alimat. Kidney problems, including kidney failure. Adverse reactions observed in pediatric patients studied were similar to those observed in adults. Tell your healthcare provider if you have kidney problems and take a medicine that contains ibuprofen.

ALIMTA is indicated, in combination with cisplatin, for the initial treatment of patients with malignant pleural mesothelioma MPM whose disease is unresectable or who are otherwise not candidates for curative surgery. ALIMTA is contraindicated in patients who have a history of severe hypersensitivity reaction to pemetrexed. Based on Kaplan-Meier estimation. Tell your healthcare provider right away if you get any new or worsening symptoms of shortness of breath, cough, or fever. Tell your healthcare provider right away if you develop blisters, skin sores, skin peeling, or painful sores, or ulcers in your mouth, nose, throat or genital area.

If concomitant ibuprofen use cannot packge avoided, monitor patients more frequently for ALIMTA adverse reactions, including myelosuppression, renal, and gastrointestinal toxicity.

Radiation recall is a skin reaction that can happen in people who have received radiation treatment in the past and are treated with ALIMTA.


Males of Reproductive Potential: Obtain a complete blood count at the beginning of each cycle. It is not apckage whether these effects on fertility are reversible.

ALIMTA® (Pemetrexed) and Pharmacokinetics

Your healthcare provider will prescribe a medicine called a corticosteroid for you to take 2 times a day for 3 days, beginning the day before each treatment with ALIMTA. Tell your healthcare provider if you get swelling, blistering, or a rash that looks like a sunburn in an area that was previously treated with radiation.

Talk to your healthcare provider if this is a concern for you. Ibuprofen increases exposure AUC of pemetrexed. Advise males with female partners of alimtx potential to use effective contraception during treatment with ALIMTA and for 3 months after the final dose. Langer CJ, et al. Advise pregnant women of the potential risk to the fetus.

Advanced NS NSCLC Treatment | ALIMTA (pemetrexed for injection)

The risk of myelosuppression is increased in patients who do not receive vitamin supplementation. Monitor patients for inflammation or blistering in areas of previous radiation treatment.

Go to alimts for additional indications. It is very important to take folic acid by mouth and receive vitamin B 12 injections from your healthcare provider during your treatment with ALIMTA to lower your risk of harmful side effects. Scagliotti GV, et al.